Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-26-000049
Filing Date
2026-05-07
Accepted
2026-05-07 08:23:35
Documents
68
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20260331.htm   iXBRL 10-Q 759259
2 EX-3.3 exhibit33.htm EX-3.3 90137
3 EX-3.4 exhibit34.htm EX-3.4 91556
4 EX-3.5 exhibit35.htm EX-3.5 100227
5 EX-3.6 exhibit36.htm EX-3.6 94690
6 EX-3.7 exhibit37amendedandrestate.htm EX-3.7 113202
7 EX-31.1 auph-2026q1exx311.htm EX-31.1 10761
8 EX-31.2 auph-2026q1exx312.htm EX-31.2 10916
9 EX-32.1 auph-2026q1exx321.htm EX-32.1 5239
10 EX-32.2 auph-2026q1exx322.htm EX-32.2 5266
16 auphlogoregistered.jpg GRAPHIC 17097
17 auphlogoregistered1.jpg GRAPHIC 17097
18 auphlogoregistered2.jpg GRAPHIC 17097
19 auphlogoregistered3.jpg GRAPHIC 17097
  Complete submission text file 0001600620-26-000049.txt   5560928

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20260331.xsd EX-101.SCH 29416
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20260331_cal.xml EX-101.CAL 70044
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20260331_def.xml EX-101.DEF 136850
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20260331_lab.xml EX-101.LAB 516795
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20260331_pre.xml EX-101.PRE 336572
72 EXTRACTED XBRL INSTANCE DOCUMENT auph-20260331_htm.xml XML 579627
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 26951017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)